1983
DOI: 10.1055/s-2007-1018741
|View full text |Cite
|
Sign up to set email alerts
|

High-Dose Conjugated Estrogens do not Reduce Antithrombin III Activity in Tall Girls

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1990
1990
1998
1998

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…Further studies on the influence of oral contraceptives on coagulation confirm an increase of coagulation factors II, VII, IX, X, XII, of fibrinogen, protein C, and plasminogen, as well as a decrease of antithrombin III and of protein S 1634 35 Petrykowski and Schmidt7observed no decrease of antithrombin III during tall stature treatment with 7.5 mg conjugated oestrogens, and suggested that the conjugated nature of the oestrogen preparation accounted for this effect. Deficiency of antithrombin III is known to be associated with an increased risk of thrombosis 7…”
Section: Discussionmentioning
confidence: 92%
“…Further studies on the influence of oral contraceptives on coagulation confirm an increase of coagulation factors II, VII, IX, X, XII, of fibrinogen, protein C, and plasminogen, as well as a decrease of antithrombin III and of protein S 1634 35 Petrykowski and Schmidt7observed no decrease of antithrombin III during tall stature treatment with 7.5 mg conjugated oestrogens, and suggested that the conjugated nature of the oestrogen preparation accounted for this effect. Deficiency of antithrombin III is known to be associated with an increased risk of thrombosis 7…”
Section: Discussionmentioning
confidence: 92%